Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Alger Weatherbie Specialized Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"Small-cap growth fund outperformed in Q4 2024 with 3.90% return, driven by AI-powered lending platform Upstart, genetic testing leader Natera, and semiconductor company Semtech. Portfolio focused on secular themes including AI, cloud computing, and genomic innovations."
The Alger Weatherbie Specialized Growth Fund outperformed the Russell 2500 Growth Index in Q4 2024, returning 3.90% versus 2.43% for the benchmark. The fund maintains a focused portfolio of approximately 50 small and mid-cap companies positioned around secular growth themes. Key contributors included Upstart Holdings, an AI-powered lending platform that reported solid Q3 results with recovering origination volumes and improved funding partnerships. Natera, a genetic testing company, benefited from accelerated growth in its Signatera oncology test and market share gains in women's health. Semtech Corporation, a semiconductor company, delivered strong results with notable data center growth of 58% quarter-over-quarter. The portfolio is positioned around secular themes including corporate digitization, cloud computing growth, and AI at an inflection point. In healthcare, the managers see compelling opportunities in surgical technologies and genomic sequencing innovations. Top detractors included Neogen, Montrose Environmental, and Tandem Diabetes Care, though the managers remain constructive on the underlying secular trends driving their investment thesis.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
The fund maintains a focused portfolio of approximately 50 holdings with named positions and specific weightings disclosed (Upstart 5.14%, Natera 5.94%, Semtech 5.32%). The managers provide detailed thesis explanations for each holding and express clear conviction in secular themes. However, the diversified nature of 50 holdings and some hedged language around external factors prevents a higher score.
Growth Outlook
The manager expresses cautious optimism about secular themes creating attractive investment opportunities, particularly in AI, cloud computing, and healthcare innovations. However, they acknowledge market volatility from Fed policy uncertainty and rising yields, resulting in a mildly positive but measured outlook.
Risk Appetite
The fund maintains a focused portfolio of approximately 50 holdings with concentrated positions in growth themes. The managers continue to invest in secular trends despite some near-term headwinds, indicating a moderate risk-on positioning tilted toward growth opportunities.
Capital Deployment
No specific cash level changes or deployment activity is mentioned in the letter. The discussion focuses on existing portfolio performance and secular themes without indicating net buying or selling activity. This appears to be a steady-state quarter with no significant capital deployment changes.
Forward Guidance
The managers express confidence in secular themes creating attractive investment opportunities ahead, particularly in healthcare innovations and technology. They maintain conviction in their positioning around AI, cloud computing, and genomics, suggesting selective deployment bias toward these themes.
Language Signal
Language is balanced with more opportunity-focused terms like attractive investment opportunities, compelling opportunities, and promising growth potential, but tempered by acknowledgment of external factors, regulatory concerns, and market volatility. Net positive but measured tone.
Perceived Risk
The manager acknowledges several specific risks including rising Treasury yields, Fed policy uncertainty, fiscal deficit concerns, and regulatory headwinds affecting some holdings. However, these risks are discussed in context rather than as central concerns, and the manager maintains conviction in secular themes despite these headwinds.
Opportunity Density
The manager sees attractive investment opportunities across multiple secular themes including AI, cloud computing, genomics, and medical devices. They identify compelling opportunities ahead in healthcare innovations and maintain conviction in technology trends, suggesting a moderately rich opportunity set in their focused areas.
Time Horizon
The fund seeks long-term capital appreciation and focuses on secular themes that are described as creating opportunities ahead. The managers discuss multi-year trends like AI inflection points and healthcare innovations without specific near-term catalyst dependency, indicating a medium to long-term investment horizon of 2-5 years.
